Liver function testing on the Abaxis Piccolo Xpress: Use in Ebola virus disease protocols

Clinica Chimica Acta

Volumn 446, Issue , 2015, Pages 119-127

  Owen, William E ^a   Caron, Justin E ^b   Genzen, Jonathan R ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Biosafety; Ebola; Liver function testing; Point of care

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOSAFETY; CHEMICAL ANALYZER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EBOLA HEMORRHAGIC FEVER; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; LIVER FUNCTION TEST; LIVER LEVEL; MALE; NONHUMAN; NORMAL HUMAN; PIPETTE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VALIDATION STUDY; BLOOD; DEVICE SAFETY; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HOSPITAL INFORMATION SYSTEM; ISOLATION AND PURIFICATION; LABORATORY; LABORATORY AUTOMATION; LIVER; METABOLISM; OCCUPATIONAL HEALTH; ORGANIZATION AND MANAGEMENT; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; STANDARDS; UNITED STATES; VIROLOGY;

EBOLA VIRUS;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; AMYLASES; ASPARTATE AMINOTRANSFERASES; AUTOMATION, LABORATORY; BILIRUBIN; EBOLAVIRUS; EQUIPMENT SAFETY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMORRHAGIC FEVER, EBOLA; HUMANS; LABORATORIES; LIVER; LIVER FUNCTION TESTS; MALE; OCCUPATIONAL HEALTH; POINT-OF-CARE SYSTEMS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTAH;

EID: 84928725022     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.03.044     Document Type: Article

References (30)

1. Lee E.J., Shin S.D., Song K.J., et al. A point-of-care chemistry test for reduction of turnaround and clinical decision time. Am J Emerg Med 2011, 29:489-495.
2. Clinical Laboratory Improvement Amendments (CLIA) How to obtain a CLIA certificate of waiver. Centers for Medicare and Medicaid Services. Brochure #6 March 2006, http://www.cms.gov/Regulations-and-Guidance/legislation/CLIA/downloads/howobtaincertificateofwaiver.pdf.
3. Decision guide for CDC consultation and Ebola virus disease (EVD) testing 2014, Utah Department of Health. http://health.utah.gov/epi/diseases/ebola/CDC_DecisionTree_EVDtesting.pdf.
4. Schembri C.T., Burd T.L., Kopf-Sill A.R., Shea L.R., Braynin B. Centrifugation and capillarity integrated into a multiple analyte whole blood analyser. J Autom Chem 1995, 17:99-104.
5. Schembri C.T., Ostoich V., Lingane P.J., Burd T.L., Buhl S.N. Portable simultaneous multiple analyte whole-blood analyzer for point-of-care testing. Clin Chem 1992, 38:1665-1670.
6. Kazmierczak S.C., Ostoich V., Aron K., Hickey A., Kazmierczak D.E., Bleile D.M. Clinical evaluation of an algorithm for short sample detection on a multi-analyte panel using a point-of-care analyzer. Clin Chem 2004, 50:1947-1949.
7. Technical briefs (Abaxis website) http://www.abaxis.com/support/technical_briefs.html.
8. Schnabl K.L., Tarek M., Cursio C., Yip P.M. Evaluation of the Piccolo Xpress chemistry analyzer for point of care testing of plasma liver function markers, electrolytes and metabolites. Clin Biochem 2008, 41:1284-1285.
9. Park H., Ko D.H., Kim J.Q., Song S.H. Performance evaluation of the Piccolo Xpress point-of-care chemistry analyzer. Korean J Lab Med 2009, 29:430-438.
10. Piccolo Liver Panel Plus Package Insert. PN: 400-7060-1 Rev. S. April 2014 2014, Abaxis, Inc, Union City, CA.
11. How U.S. clinical laboratories can safely manage specimens from persons under investigation for Ebola virus disease. Centers for Disease Control and Prevention 2014, http://www.cdc.gov/vhf/ebola/hcp/safe-specimen-management.html.
12. Croghan C.W., Egeghy P.P. Methods of dealing with values below the limit of detection using SAS. Presented at Southern SAS User Group, St. Petersburg, FL, September 22-24, 2003 2003, http://analytics.ncsu.edu/sesug/2003/SD08-Croghan.pdf.
13. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation 2014, Westgard QC website. http://www.westgard.com/biodatabase1.htm.
14. Ricós C., Alvarez V., Cava F., García-Lario J.V., Hernández A., Jiménez C.V., et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999, 59:491-500.
15. Guidance for Industry: Bioanalytical Method Validation May 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
16. Review of Human-to-Human Transmission of Ebola Virus. Centers for Disease Control and Prevention 2014, http://www.cdc.gov/vhf/ebola/transmission/human-transmission.html.
17. Laboratory guidelines for handling specimens from patients under investigation (PUI) for Ebola virus disease (EVD) in Nebraska October 24 2014, Nebraska Department of Health and Human Services, Health Alert Network Advisory, http://dhhs.ne.gov/publichealth/han%20Documents/ADVISORY102414.pdf.
18. Point of care testing for patients suspected of Ebola virus disease or confirmed Ebola virus disease October 30 2014, Florida Department of Health Version 1.0, http://www.fha.org/files/JohnW/EM/Ebola/FDOH_31October2014_Point-of-Care-Testing-for-Patients-Suspected-of-EVD_Final.pdf.
19. Laboratory guidelines for handling routine specimens from patients with suspected or confirmed Ebola virus disease November 10 2014, Mississippi State Department of Health, http://msdh.ms.gov/msdhsite/_static/resources/6028.pdf?rss=.
20. Interim biosafety guidelines for laboratories handling specimens from patients under investigation for Ebola virus disease October 19 2014, http://www.phac-aspc.gc.ca/id-mi/vhf-fvh/ebola-biosafety-biosecurite-eng.php.
21. Revised NYS/NYC laboratory guidelines for handling specimens from patients with suspected or confirmed Ebola virus disease September 16 2014, New York State Department of Health, http://www.nyc.gov/html/doh/downloads/pdf/cd/ebola-lab-guidelines.pdf.
22. Interim laboratory guidelines for handling/testing specimens from cases or suspected cases of hemorrhagic fever virus (HFV) September 12, 2014, American Society for Microbiology, https://www.asm.org/images/PSAB/Ebola9-10-14.pdf. 2nd ed.
23. Hill C.E., Burd E.M., Kraft C.S., Ryan E.L., Duncan A., Winkler A.M., et al. Laboratory test support for Ebola patients within a high-containment facility. Lab Med 2014, 45:e109-e111.
24. Courage K.H. Inside the 4 U.S. biocontainment hospitals that are stopping Ebola October 24 2014, Scientific American, http://www.scientificamerican.com/article/inside-the-4-u-s-biocontainment-hospitals-that-are-stopping-ebola-video/.
25. Jones P. Laboratory and hospital Ebola response October 28 2014, Lab Medicine Lablogatory, http://labmedicineblog.com/2014/10/28/laboratory-and-hospital-ebola-response/.
26. Total bilirubin special (BILTS) package insert. 2010-10V6 2010, Roche Diagnostics, Indianapolis, IN.
27. Alkaline Phosphatase acc. to IFCC Gen.2 (ALP2) Package Insert. 2012-02, V 7 2012, Roche Diagnostics, Indianapolis, IN.
28. Alpha-Amylase EPS ver.2 (AMYL2) Package Insert. 2012-04, V 7 2012, Roche Diagnostics, Indianapolis, IN.
29. Boyanton B.L., Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002, 48:2242-2247.
30. Williams K.M., Williams A.E., Kline L.M., Dodd R.Y. Stability of serum alanine aminotransferase activity. Transfusion 1987, 27:431-433.